“[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-Per-Responder Analysis]”. 2025. Farmeconomia. Health Economics and Therapeutic Pathways 26 (1). https://doi.org/10.7175/fe.v26i1.1571.